Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
June 17, 2020
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
June 17, 2020
Impel Neuropharma Presents Data From INP104 Clinical Program in Acute Migraine at the 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting
June 12, 2020
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt) and Azacitidine in Patients with TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia at the 25th European Hematology Association Annual Meeting
June 11, 2020
IDEAYA Biosciences Selected to Join Russell 3000® Index
June 10, 2020
Impel NeuroPharma Announces Primary Objectives Met in Pivotal Phase 3 Registration Study of INP104 for the Treatment of Acute Migraine
June 10, 2020
IDEAYA Announces Nomination of Development Candidate, IDE397, for MAT2A Synthetic Lethality Program Targeting MTAP-Deletion Patient Population
June 3, 2020
NodThera Announces Close of $55 Million Series B Financing
June 3, 2020
Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)
May 29, 2020
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases
May 28, 2020
Rallybio Further Broadens Drug Development Capabilities with Addition of Róisín Armstrong, PhD
« Previous Page
1
…
39
40
41
42
43
…
103